Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxiang Suling Shuanghua Yin
- Development stage
- Unknown
- Lead developer
- Beijing University of Chinese Medicine
- Administration
- Oral
01
Overview
Huoxiang Suling Shuanghua Yin is a modern Chinese herbal combination developed by a team led by Professor Wang Linyuan at Beijing University of Chinese Medicine, specifically for the prevention of COVID-19 and influenza. The formula was created under the guidance of traditional Chinese medicine (TCM) epidemic prevention theory, integrating clinical experience from the COVID-19 pandemic and modern scientific research. It is designed as a preventive remedy to support immune function, clear heat, resolve dampness, and provide antiviral effects. The product uses food-grade medicinal ingredients with gentle action and employs volatile oil encapsulation technology for enhanced efficacy. It has been approved for sale in several countries including the US and Europe[2][3][5]. Mechanistically, it acts through multiple TCM principles such as aromatic dispelling of pathogens (芳香辟秽), strengthening spleen function to remove dampness (健脾利湿), supporting lung health (益肺驱痰), and boosting vital energy or "upright qi" (扶助正气)[8].
- Brand names
- Huoxiang Suling Shuanghua Yin
- Other names
- 藿香苏苓双花饮
02
Targets
CD14 (Monocyte differentiation antigen CD14)HA (Hemagglutinin)NP (Taï Forest ebolavirus nucleoprotein)MYD88 (Myeloid differentiation primary response protein MyD88)RELA (Nuclear Factor Kappa B Subunit p65)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on Huoxiang Suling Shuanghua Yin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huoxiang Suling Shuanghua Yin.